As noted in their 4C, this will be the last R&D tax incentive payment they'll be eligible for due to their increased revenue growth. But it should put them in a good position for Q4.
In April, the company also received $2.9m in COVID-related funding packages in the US and Switzerland. So that should further help offset expenses in the final quarter.
